Disease Markers / 2015 / Article / Tab 2

Research Article

Assessment of Immunological Biomarkers in the First Year after Heart Transplantation

Table 2

Data sets with imputed values of the different immunological parameters CD25, CD95, IL2, IFN, plasmacytoid and myeloid dendritic cells, IP10, and MIG at different time points during the first year after heart transplantation. Data are represented as mean ± standard deviations.

1st quarter2nd quarter2nd half yearAdjusted value

CD2533.6%  ±  21.0%34.7%  ±  21.9%33.4%  ±  20.6%0.78
CD9539.2%  ±  23.7%46.3%  ±  26.9%45.6%  ±  28.7%0.22
IL-29.2%  ±  11.6%16.2%  ±  13.8%18.3%  ±  15.5%<0.01
IFN10.7%  ±  12.4%17.9%  ±  12.8%24.9%  ±  21.4%<0.01
pDCs18.8%  ±  12.2%26.4%  ±  10.5%31.0%  ±  11.9%<0.01
mDCs41.2%  ±  20.9%49.7%  ±  15.0%47.7%  ±  21.0%0.06
pDC/mDC ratio0.78  ±  1.170.71  ±  0.711.05  ±  1.220.24
IP1042.1 pg/mL  ±  42.0 pg/mL35.1 pg/mL  ±  25.5 pg/mL45.5 pg/mL  ±  43.9 pg/mL0.25
MIG 29.6 pg/mL  ±  38.3 pg/mL23.7 pg/mL  ±  16.6 pg/mL25.4 pg/mL  ±  13.6 pg/mL0.40

CD25, alpha chain of the interleukin-2 receptor; CD95, Fas receptor; IFN, interferon g; IL2, interleukin-2; IP10, CXC chemokine ligand 10; mDCs, myeloid dendritic cells; MIG, CXC chemokine ligand 9; pDCs, plasmacytoid dendritic cells.